Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Cash flows from (used in) operations before changes in working capital |
3 375
SEK
|
2 411
SEK
|
| Adjustments for decrease (increase) in trade and other receivables |
156,000,000
SEK
|
44,000,000
SEK
|
| Adjustments for increase (decrease) in trade and other payables |
247,000,000
SEK
|
105,000,000
SEK
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
464,000,000
SEK
|
579,000,000
SEK
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of biological assets |
166,000,000
SEK
|
128,000,000
SEK
|
| Proceeds from sales of biological assets |
424,000,000
SEK
|
69,000,000
SEK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
1 741
SEK
|
567,000,000
SEK
|